A population-based study of the association between bullous pemphigoid and neurologic disorders

被引:86
作者
Brick, Katherine E. [1 ]
Weaver, Chad H. [1 ]
Savica, Rodolfo [6 ]
Lohse, Christine M. [3 ]
Pittelkow, Mark R. [5 ]
Boeve, Bradley F. [4 ]
Gibson, Lawrence E. [1 ,2 ]
Camilleri, Michael J. [1 ,2 ]
Wieland, Carilyn N. [1 ,2 ]
机构
[1] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Anat Pathol, Rochester, MN 55905 USA
[3] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Dermatol, Scottsdale, AZ USA
[6] Univ Utah, Dept Neurol, Div Sleep & Movement Disorders, Salt Lake City, UT 84112 USA
关键词
bullous diseases; bullous pemphigoid; epidemiology; immunobullous; immunodermatology; pemphigoid; ROCHESTER EPIDEMIOLOGY PROJECT; COLLAGEN-XVII; DISEASES; ANTIBODIES; MORTALITY; DEMENTIA; SYSTEM; RISK;
D O I
10.1016/j.jaad.2014.07.052
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Bullous pemphigoid (BP) has been associated with neurologic disorders. Objective: We sought to analyze the association between BP and neurologic disorders. Methods: We retrospectively identified residents of Olmsted County, Minnesota, with a first lifetime diagnosis of BP between January 1, 1960, and December 31, 2009. Three age- and sex-matched Olmsted County, Minnesota, residents without BP were selected as control subjects for each patient. We compared history of or development of neurologic disorders (dementia, Alzheimer disease, Parkinson disease, multiple sclerosis, cerebrovascular disease, and seizures) between groups using case-control and cohort designs. Results: In all, 87 patients with BP were identified and matched to 261 control subjects. The odds of a previous diagnosis of any neurologic disorder or a history of dementia were significantly increased among cases compared with controls (odds ratio 6.85; 95% confidence interval [CI] 3.00-15.64; P < .001; and odds ratio 6.75; 95% CI 2.08-21.92; P = .002, respectively). Both Parkinson disease (hazard ratio 8.56; 95% CI 1.55-47.25; P = .01) and any type of neurologic disorder (hazard ratio 2.02; 95% CI 1.17-3.49; P = .01) were significantly more likely to develop during follow-up in patients with than without BP. Limitations: Small geographic area and retrospective study design are limitations. Conclusion: Findings confirmed an association of BP with neurologic disorders, especially dementia and Parkinson disease.
引用
收藏
页码:1191 / 1197
页数:7
相关论文
共 32 条
[1]   Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case-Control Study [J].
Bastuji-Garin, Sylvie ;
Joly, Pascal ;
Lemordant, Pauline ;
Sparsa, Agnes ;
Bedane, Christophe ;
Delaporte, Emmanuel ;
Roujeau, Jean-Claude ;
Bernard, Philippe ;
Guillaume, Jean-Claude ;
Ingen-Housz-Oro, Saskia ;
Maillard, Herve ;
Pauwels, Catherine ;
Picard-Dahan, Catherine ;
Dutronc, Yes ;
Richard, Marie-Aleth .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (03) :637-643
[2]   INCIDENCE AND DISTRIBUTION OF SUBEPIDERMAL AUTOIMMUNE BULLOUS SKIN DISEASES IN 3 FRENCH REGIONS [J].
BERNARD, P ;
VAILLANT, L ;
LABEILLE, B ;
BEDANE, C ;
ARBEILLE, B ;
DENOEUX, JP ;
LORETTE, G ;
BONNETBLANC, JM ;
PROST, C .
ARCHIVES OF DERMATOLOGY, 1995, 131 (01) :48-52
[3]   Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009 [J].
Brick, Katherine E. ;
Weaver, Chad H. ;
Lohse, Christine M. ;
Pittelkow, Mark R. ;
Lehman, Julia S. ;
Camilleri, Michael J. ;
Al-Hashimi, Mustafa ;
Wieland, Carilyn N. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (01) :92-99
[4]   THE MOUSE DYSTONIA MUSCULORUM GENE IS A NEURAL ISOFORM OF BULLOUS PEMPHIGOID ANTIGEN-1 [J].
BROWN, A ;
BERNIER, G ;
MATHIEU, M ;
ROSSANT, J ;
KOTHARY, R .
NATURE GENETICS, 1995, 10 (03) :301-306
[5]   Sera of Elderly Bullous Pemphigoid Patients with Associated Neurological Diseases Recognize Bullous Pemphigoid Antigens in the Human Brain [J].
Chen, Jinbo ;
Li, Li ;
Chen, Jiang ;
Zeng, Yueping ;
Xu, Haoxiang ;
Song, Yang ;
Wang, Baoxi .
GERONTOLOGY, 2011, 57 (03) :211-216
[6]   Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study [J].
Chen, Y. J. ;
Wu, C. Y. ;
Lin, M. W. ;
Chen, T. J. ;
Liao, K. K. ;
Chen, Y. C. ;
Hwang, C. Y. ;
Chu, S. Y. ;
Chen, C. C. ;
Lee, D. D. ;
Chang, Y. T. ;
Wang, W. J. ;
Liu, H. N. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) :593-599
[7]   Collagen XVII and BPAG1 expression in the retina: Evidence for an anchoring complex in the central nervous system [J].
Claudepierre, T ;
Manglapus, MK ;
Marengi, N ;
Radner, S ;
Champliaud, MF ;
Tasanen, K ;
Bruckner-Tuderman, L ;
Hunter, DD ;
Brunken, WJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 2005, 487 (02) :190-203
[8]   Neurological disorders in patients with bullous pemphigoid [J].
Cordel, Nadege ;
Chosidow, Olivier ;
Hellot, Marie-France ;
Delaporte, Emmanuel ;
Lok, Catherine ;
Vaillant, Loic ;
Bernard, Philippe ;
D'Incan, Michel ;
Roujeau, Jean Claude ;
Joly, Pascal .
DERMATOLOGY, 2007, 215 (03) :187-191
[9]   Mortality of bullous pemphigoid in Switzerland: a prospective study [J].
Cortes, B. ;
Marazza, G. ;
Naldi, L. ;
Combescure, C. ;
Borradori, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) :368-374
[10]   Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment A Multicenter, Prospective Study [J].
Fichel, Fanny ;
Barbe, Coralie ;
Joly, Pascal ;
Bedane, Christophe ;
Vabres, Pierre ;
Truchetet, Francois ;
Aubin, Francois ;
Michel, Catherine ;
Jegou, Juliette ;
Grange, Florent ;
Antonicelli, Frank ;
Bernard, Philippe .
JAMA DERMATOLOGY, 2014, 150 (01) :25-33